Analytical Data
-
Gene name
ANKRD40
- Application
-
Alternative Names
ANKRD40Ankyrin repeat domain-containing Protein 40
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6AI12
-
Expression Region
1-368aa
-
AA Sequence
MNALLEQKEQQERLREAAALGDIREVQKLVESGVDVNSQNEVNGWTCLHWACKRNHGQVVSYLLKSGADKEILTTKGEMPVQLTSRREIRKIMGVEEEDDDDDDDDNLPQLKKESELPFVPNYLANPAFPFIYTPTAEDSAQMQNGGPSTPPASPPADGSPPLLPPGEPPLLGTFPRDHTSLALVQNGDVSAPSAILRTPESTKPGPVCQPPVSQSRSLFSSVPSKPPMSLEPQNGTYAGPAPAFQPFFFTGAFPFNMQELVLKVRIQNPSLRENDFIEIELDRQELTYQELLRVCCCELGVNPDQVEKIRKLPNTLLRKDKDVARLQDFQELELVLMISENNFLFRNAASTLTERPCYNRRASKLTY
-
Molecular Weight
67.5 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ANKRD40, also known as Ankyrin Repeat Domain 40, is a protein implicated in various cellular processes, including cell signaling and protein-protein interactions. Its role in human health and disease, particularly in relation to cancer and neurodegenerative disorders, has drawn significant research interest. The study of ANKRD40 recombinant proteins is crucial for understanding the molecular mechanisms underlying its functions and exploring potential therapeutic applications. Researchers aim to explore the structural and functional properties of ANKRD40, which can help identify its interaction partners and signaling pathways. Recombinant expression systems enable the production of high-purity ANKRD40, facilitating detailed biochemical and biophysical analyses. Such studies are vital for elucidating the role of ANKRD40 in cellular contexts and may open avenues for drug development targeting this protein. Moreover, understanding the regulation of ANKRD40 expression and its post-translational modifications could provide insights into its involvement in disease mechanisms, potentially leading to novel strategies for diagnosis and treatment. Given the complexity of cellular signaling networks, further investigation into ANKRD40 may reveal its contributions to maintaining cellular homeostasis and its implications in pathological states. Overall, the research on ANKRD40 recombinant proteins represents a critical step toward uncovering the biological significance of this enigmatic protein.
